XML 19 R7.htm IDEA: XBRL DOCUMENT
v3.25.1

Restructuring Costs | 9 Months Ended
--- | ---
Dec. 31, 2024
Restructuring and Related Activities [Abstract] |
Restructuring and Impairment Costs Disclosure | RESTRUCTURING AND IMPAIRMENT COSTS Universal regularly reviews its business for opportunities to realize efficiencies, reduce costs, and realign its operations in response to business changes. Restructuring and impairment costs are periodically incurred in connection with those activities. Tobacco Operations During the nine months ended December 31, 2024, the Company began consolidating its European sheet tobacco operations into the Company's facility in the Netherlands, by initiating a wind-down of activities at its sheet facility in Germany, incurring $10.5 million of restructuring and impairment costs. Additionally, during the nine months ended December 31, 2024, the Company also incurred $0.1 million of termination and impairment costs in other areas of the Tobacco Operations segment. During the nine months ended December 31, 2023, the Company incurred $1.8 million of restructuring and impairment costs for its Global Labs Services ("GLS") facility in Wilson, NC. GLS provided testing for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors, and had capabilities for testing non-tobacco products. The restructuring and impairment costs were net of approximately $0.2 million of income from the sale of GLS processes and procedures to a third-party buyer. Additionally, during the nine months ended December 31, 2023, the Company also incurred $1.7 million of termination and impairment costs in other areas of the Tobacco Operations segment. A summary of the restructuring and impairment costs recorded for the three and nine months ended December 31, 2024 and 2023 were as follows:
|  | Three Months Ended December 31, |  | Nine Months Ended December 31,
(in thousands) |  | 2024 |  | 2023 |  | 2024 |  | 2023
Restructuring costs: |  |  |  |  |  |  |  |
Employee termination benefits |  | $ | — |  |  | $ | 212 |  |  | $ | 4,342 |  |  | $ | 1,615 |
Other |  | — |  |  | — |  |  | 1,372 |  |  | (182) |
Total restructuring costs |  | — |  |  | 212 |  |  | 5,714 |  |  | 1,433 |
Impairment costs: |  |  |  |  |  |  |  |
Property, plant and equipment |  | — |  |  | 712 |  |  | 4,859 |  |  | 2,090 |
Total impairment costs |  | — |  |  | 712 |  |  | 4,859 |  |  | 2,090 |
Total restructuring and impairment costs |  | $ | — |  |  | $ | 924 |  |  | $ | 10,573 |  |  | $ | 3,523 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration